Knight GM - Search Results

1

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG. Knight GM, et al. PLoS One. 2015 Dec 30;10(12):e0145796. doi: 10.1371/journal.pone.0145796. eCollection 2015. PLoS One. 2015. PMID: 26717007 Free PMC article.

2

Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.

Dodd PJ, Knight GM, Lawn SD, Corbett EL, White RG. Dodd PJ, et al. Among authors: knight gm. PLoS One. 2013 Sep 17;8(9):e75466. doi: 10.1371/journal.pone.0075466. eCollection 2013. PLoS One. 2013. PMID: 24069418 Free PMC article.

3

Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.

Fofana MO, Knight GM, Gomez GB, White RG, Dowdy DW. Fofana MO, et al. Among authors: knight gm. PLoS One. 2014 May 9;9(5):e96389. doi: 10.1371/journal.pone.0096389. eCollection 2014. PLoS One. 2014. PMID: 24816692 Free PMC article.

4

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

Knight GM, Griffiths UK, Sumner T, Laurence YV, Gheorghe A, Vassall A, Glaziou P, White RG. Knight GM, et al. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5. doi: 10.1073/pnas.1404386111. Epub 2014 Oct 6. Proc Natl Acad Sci U S A. 2014. PMID: 25288770 Free PMC article.

5

Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.

Shrestha S, Knight GM, Fofana M, Cohen T, White RG, Cobelens F, Dowdy DW. Shrestha S, et al. Among authors: knight gm. Open Forum Infect Dis. 2014 Aug 30;1(2):ofu073. doi: 10.1093/ofid/ofu073. eCollection 2014 Sep. Open Forum Infect Dis. 2014. PMID: 25734143 Free PMC article.

6

Tuberculosis prevention in South Africa.

Knight GM, Dodd PJ, Grant AD, Fielding KL, Churchyard GJ, White RG. Knight GM, et al. PLoS One. 2015 Apr 7;10(4):e0122514. doi: 10.1371/journal.pone.0122514. eCollection 2015. PLoS One. 2015. PMID: 25849558 Free PMC article.

7

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Knight GM, Colijn C, Shrestha S, Fofana M, Cobelens F, White RG, Dowdy DW, Cohen T. Knight GM, et al. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S147-54. doi: 10.1093/cid/civ579. Clin Infect Dis. 2015. PMID: 26409276 Free PMC article.

8

Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.

Knight GM, Dharan NJ, Fox GJ, Stennis N, Zwerling A, Khurana R, Dowdy DW. Knight GM, et al. Int J Infect Dis. 2016 Jan;42:17-23. doi: 10.1016/j.ijid.2015.10.024. Epub 2015 Nov 3. Int J Infect Dis. 2016. PMID: 26546234 Free PMC article. Review.

9

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

Rhodes SJ, Knight GM, Fielding K, Scriba TJ, Pathan AA, McShane H, Fletcher H, White RG. Rhodes SJ, et al. Among authors: knight gm. Tuberculosis (Edinb). 2016 Jan;96:37-43. doi: 10.1016/j.tube.2015.10.002. Epub 2015 Nov 11. Tuberculosis (Edinb). 2016. PMID: 26786653 Free article.

10

The transmission of Mycobacterium tuberculosis in high burden settings.

Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, White RG, Cohen T, Cobelens FG, Wood R, Moore DA, Abubakar I. Yates TA, et al. Among authors: knight gm. Lancet Infect Dis. 2016 Feb;16(2):227-38. doi: 10.1016/S1473-3099(15)00499-5. Epub 2016 Jan 26. Lancet Infect Dis. 2016. PMID: 26867464 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters